1. Home
  2. AQB vs PRFX Comparison

AQB vs PRFX Comparison

Compare AQB & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQB
  • PRFX
  • Stock Information
  • Founded
  • AQB 1991
  • PRFX 2007
  • Country
  • AQB United States
  • PRFX Israel
  • Employees
  • AQB N/A
  • PRFX N/A
  • Industry
  • AQB
  • PRFX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AQB
  • PRFX Health Care
  • Exchange
  • AQB Nasdaq
  • PRFX Nasdaq
  • Market Cap
  • AQB 2.9M
  • PRFX 2.9M
  • IPO Year
  • AQB N/A
  • PRFX 2020
  • Fundamental
  • Price
  • AQB $0.78
  • PRFX $1.38
  • Analyst Decision
  • AQB
  • PRFX Hold
  • Analyst Count
  • AQB 0
  • PRFX 1
  • Target Price
  • AQB N/A
  • PRFX N/A
  • AVG Volume (30 Days)
  • AQB 228.7K
  • PRFX 316.5K
  • Earning Date
  • AQB 08-05-2025
  • PRFX 08-14-2025
  • Dividend Yield
  • AQB N/A
  • PRFX N/A
  • EPS Growth
  • AQB N/A
  • PRFX N/A
  • EPS
  • AQB N/A
  • PRFX N/A
  • Revenue
  • AQB N/A
  • PRFX N/A
  • Revenue This Year
  • AQB N/A
  • PRFX N/A
  • Revenue Next Year
  • AQB N/A
  • PRFX N/A
  • P/E Ratio
  • AQB N/A
  • PRFX N/A
  • Revenue Growth
  • AQB N/A
  • PRFX N/A
  • 52 Week Low
  • AQB $0.47
  • PRFX $1.25
  • 52 Week High
  • AQB $1.94
  • PRFX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • AQB 48.77
  • PRFX 35.23
  • Support Level
  • AQB $0.74
  • PRFX $1.25
  • Resistance Level
  • AQB $0.84
  • PRFX $1.48
  • Average True Range (ATR)
  • AQB 0.06
  • PRFX 0.11
  • MACD
  • AQB 0.00
  • PRFX 0.00
  • Stochastic Oscillator
  • AQB 34.83
  • PRFX 29.53

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: